Skip to content
HowShorted

How shorted is Sagimet Biosciences Inc.? SGMT

#238most shorted US stockof 3,805 ranked stocks, more shorted than 93%

16.51%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
+0.24
5 reports (~10 weeks)
+3.15
days to cover
10.56
Aggregate net short position time series for Sagimet Biosciences Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Sagimet Biosciences Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
11 Aug 202618.78% 31 Jul 202618.90% 14 Aug 2026+0.12
12 May 202613.91% 30 Apr 20266.82% 15 May 2026−7.09
27 Apr 202611.04% 15 Apr 202613.91% 30 Apr 2026+2.87
11 Mar 202611.25% 27 Feb 202611.67% 13 Mar 2026+0.42
13 Nov 20259.62% 31 Oct 20259.19% 14 Nov 2025−0.43
13 Aug 20259.97% 31 Jul 20258.61% 15 Aug 2025−1.36
8 May 202512.07% 30 Apr 202511.14% 15 May 2025−0.93
12 Mar 202516.22% 28 Feb 202513.02% 14 Mar 2025−3.20

Fails to deliver

The SEC's fails-to-deliver figure for SGMT: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
500
24 Aug 2026
Highest in window
200,686
9 Feb 2026
Days with a balance
58
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Sagimet Biosciences Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 201K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 202616.51%+0.24
31 Aug 202616.27%−2.63
14 Aug 202618.90%+0.12
31 Jul 202618.78%+3.00
15 Jul 202615.78%+2.42
30 Jun 202613.36%+3.92
15 Jun 20269.44%+1.66
29 May 20267.78%+0.96
15 May 20266.82%−7.09
30 Apr 202613.91%+2.87
15 Apr 202611.04%+1.14
31 Mar 20269.90%−1.77
13 Mar 202611.67%+0.42
27 Feb 202611.25%−0.70
13 Feb 202611.95%+1.48
30 Jan 202610.47%+0.62
15 Jan 20269.85%+1.39
31 Dec 20258.46%−0.66
15 Dec 20259.12%−0.32
28 Nov 20259.44%+0.25
14 Nov 20259.19%−0.43
31 Oct 20259.62%+1.16
15 Oct 20258.46%+0.06
30 Sep 20258.40%−1.15
15 Sep 20259.55%+2.13
29 Aug 20257.42%−1.19
15 Aug 20258.61%−1.36
31 Jul 20259.97%−0.52
15 Jul 202510.49%−0.78
30 Jun 202511.27%−0.55
13 Jun 202511.82%+0.45
30 May 202511.37%+0.23
15 May 202511.14%−0.93
30 Apr 202512.07%+0.19
15 Apr 202511.88%−0.40
31 Mar 202512.28%−0.74
14 Mar 202513.02%−3.20
28 Feb 202516.22%−1.62
14 Feb 202517.84%+0.96
31 Jan 202516.88%+1.28
15 Jan 202515.60%+2.04
31 Dec 202413.56%+0.02
13 Dec 202413.54%+0.09
29 Nov 202413.45%−0.78
15 Nov 202414.23%+0.63
31 Oct 202413.60%+0.62
15 Oct 202412.98%+6.55
30 Sep 20246.43%−0.30
13 Sep 20246.73%+0.68
30 Aug 20246.05%+0.13
15 Aug 20245.92%+0.36
31 Jul 20245.56%+0.06
15 Jul 20245.50%−2.00
28 Jun 20247.50%+0.05
14 Jun 20247.45%+0.12
31 May 20247.33%+0.29
15 May 20247.04%−3.26
30 Apr 202410.30%+0.62
15 Apr 20249.68%−1.31
28 Mar 202410.99%+2.63
15 Mar 20248.36%+0.80
29 Feb 20247.56%+0.28
15 Feb 20247.28%+2.24
31 Jan 20245.04%+2.13
12 Jan 20242.91%0.00
29 Dec 20232.91%+0.71
15 Dec 20232.20%−0.56
30 Nov 20232.76%+0.08
15 Nov 20232.68%–

Newest first. Scroll inside the table for earlier dates, back to 15 Nov 2023.

Frequently asked questions

How shorted is Sagimet Biosciences Inc. right now?
16.51% of Sagimet Biosciences Inc.'s (SGMT) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 238th most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this SGMT's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is SGMT's days to cover?
10.56 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.